Dipna Pharmachem Share Price

Small Cap | Pharmaceuticals and health care | BSE: 543594

₹11.80 image0.06 (0.51 %)

Last Updated: 25 Feb 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 12.32

High (₹) 12.32

Low (₹) 11.45

Prev. Close (₹) 11.74

Volume 66,000

VWAP (₹) 11.67

ROCE (%) 6.82

Industry P/E 43.77

TTM P/E 33.71

P/B Ratio 0.76

Market Cap (₹) Cr.28.37

Dividend Yield (%)--

EPS (₹) 0.90

ROE5.77%

Sales Growth (%) 64.46

Profit Growth (%)19.01

Day Range

12.3212.32

L
H

52 Week Range

6.4016.55

L
H

Historical Returns

Returns (6M)

44.79 %

Returns (1Y)

5.08 %

Returns (3Y)

-57 %

Returns (5Y)

-57 %

Returns (6M)

44.79 %

Returns (1Y)

5.08 %

Returns (3Y)

-57 %

Returns (5Y)

-57 %

SWOT Analysis

  • Strong long-term momentum: Price above long-term moving averages (EMA_200)

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 29.36

MFI 20.36

ATR 0.83

Commodity Channel Index -110.50

ROC125 38.17

ROC21 -21.33

Williams %R -92.78

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current12.2712.7313.1411.8611.4010.9910.53
Week Ago12.5912.8913.0512.4312.1311.9711.67
Month Ago15.4115.8316.3114.9314.5114.0313.61

EMA & SMA
info_icon

11.80

Current Price

EMA & SMApin

Bullish Moving Averages

4

Bearish Moving Averages

16

5 Day 11.81


9 Day 12.74


10 Day 12.84


12 Day 13.41


14 Day 13.67

20 Day 13.75


26 Day 14.09


50 Day 13.04


100 Day 10.25


200 Day 9.19

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
NEERITA SANJAY JAINbulkSell05 Feb, 2025₹16.551,17,000BSE
KALPALABDHI SECURITIES PRIVATE LIMITEDbulkSell05 Feb, 2025₹15.264,08,000BSE
NEERITA SANJAY JAINbulkBuy05 Feb, 2025₹15.051,47,000BSE
HEMANT NARESH JAIN HUFbulkBuy06 Jan, 2025₹15.702,97,000BSE
VIHA ASHOK JAINbulkSell01 Jan, 2025₹15.132,01,000BSE
GREEN PEAKS ENTERPRISES LLPbulkSell01 Jan, 2025₹14.962,04,000BSE
BONANZA PORTFOLIO LIMITEDbulkSell01 Jan, 2025₹14.492,19,000BSE
VIHA ASHOK JAINbulkBuy01 Jan, 2025₹14.192,73,000BSE
TEENA KIRTI JAINbulkBuy01 Jan, 2025₹13.923,21,000BSE
SAHIB PUNIANIbulkBuy01 Jan, 2025₹14.931,62,000BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
11 Jan, 2024Keyur Dipakkumar ShahDisposal₹13.112,88,000BSE
01 Jan, 2024Keyur Dipakkumar ShahDisposal₹10.7416,38,000BSE
01 Jan, 2024Keyur Dipakkumar ShahDisposal₹12.0590,000BSE
26 Dec, 2023Keyur Dipakkumar ShahDisposal₹12.062,10,000BSE
14 Dec, 2023Dipna Keyur ShahDisposal₹12.031,62,000BSE
14 Dec, 2023Keyur Dipakkumar ShahDisposal₹12.042,61,000BSE
09 Dec, 2023Dipna Keyur ShahDisposal₹12.011,05,000BSE
07 Dec, 2023Dipna Keyur ShahDisposal₹12.632,40,000BSE
01 Dec, 2023Dipna Keyur ShahDisposal₹12.111,53,000BSE
28 Nov, 2023Dipna Keyur ShahDisposal₹13.001,77,000BSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
18 Oct, 2023Rights issue of equity shares of Rs. 10/- in the ratio of 13:12 @ par. (RD & XD revised)12 Feb, 202412 Feb, 2024

Announcements

DateSourceDetail
24 Feb, 2025BSE IndiaPursuant to the Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e., Monday, 24th February, 2025 at the registered office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India - 380 055 which commenced at 04:00 P.M. and concluded at 04:30 P.M. inter-alia has, considered and approved 1. Raising of funds upto Rs. 99.99 Crores (Rupees Ninety-Nine Crores and Ninety-Nine Lakhs Only) by way of issue of Warrants (hereinafter referred to as 'Convertible Warrants'), through preferential allotment to the person(s)/ entity(ies) belonging to 'Promoter and Promoter Group Category' and 'Non-Promoter category', as per Chapter V of SEBI (ICDR) Regulations, 2018, subject to approval of Shareholders and other authorities concerned.
11 Feb, 2025BSE IndiaDipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/02/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Monday, 24th February, 2025, at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, to discuss and consider, inter-alia:\r\n\r\n1. Proposal of raising of funds by way of issue of Equity shares and/ or Warrants on Preferential basis.\r\n\r\n2. Any other agenda/ business matter to be discuss with the permission of Chairperson of the Board Meeting.\r\n\r\nKindly take the same on your record and oblige us.
06 Feb, 2025BSE IndiaPursuant to the Regulation 30 of the SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in their meeting held today i.e. Thursday, 6th February, 2025 which commenced at 03:00 P.M. and concluded at 03:20 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055, Gujarat, Board of Directors has decided not to proceed with the agenda of raising of funds by way of issue of Equity shares and/ or Warrants on Preferential basis.
30 Jan, 2025BSE IndiaDipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Thursday, 6th February, 2025 at 03:00 P.M., at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, to discuss and consider, inter-alia:\r\n\r\n1. Proposal of raising of funds by way of issue of Equity shares and/ or Warrants on Preferential basis.\r\n\r\n2. Any other agenda/ business matter to be discuss with the permission of Chairperson of the Board Meeting.
30 Dec, 2024BSE IndiaClarification sought on significant movement in price
30 Dec, 2024BSE IndiaThe Exchange has sought clarification from Dipna Pharmachem Ltd on December 30, 2024, with reference to Movement in Price. <BR><BR>The reply is awaited.
18 Dec, 2024BSE IndiaUnaudited Financial Results along with Limited review report
11 Dec, 2024BSE IndiaSubmission of unaudited financial reuslts
11 Dec, 2024BSE IndiaOutcome of Board Meeting held today i.e. 11th December, 2024
27 Nov, 2024BSE IndiaKindly find the attached intimation of Resignation of Company Secretary

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Preferential issue of shares--12 Feb, 202524 Feb, 2025
Preferential issue of shares--31 Jan, 202506 Feb, 2025
Preferential issue & Issue of Warrants--24 Jul, 202429 Jul, 2024
Audited Results--11 Jun, 202412 Jun, 2024
Bonus, Stock Split & Preferential issue(Revised)29 Apr, 202402 May, 2024
Bonus, Stock Split & Preferential issue--29 Apr, 202426 Apr, 2024
Half Yearly Results & Rights issue--17 Oct, 202318 Oct, 2023
Half Yearly Results & Rights issue--06 Oct, 202311 Oct, 2023
Audited Results--03 Jul, 202310 Jul, 2023
Audited Results(Revised)23 Jun, 202330 Jun, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameSept, 2024Mar, 2024Sept, 2023

About Dipna Pharmachem

Dipna Pharmachem is a Public Limited Listed company incorporated on 19/07/2011 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24100GJ2011PLC066400 and registration number is 066400. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 164.34 Cr. and Equity Capital is Rs. 24.05 Cr. for the Year ended 31/03/2024.  Read More

Parent Organisation

Not Applicable

Founded

2011

Managing Director

Mr. Keyur Dipakkumar Shah

NSE Symbol

--

Dipna Pharmachem Management

NameDesignation
Mr. Keyur Dipakkumar ShahManaging Director
Ms. Dipna Keyur ShahNon Executive Director
Mr. Nandish Shaileshbhai JaniIndependent Director
Mr. Jitendra Pradipbhai ParmarIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
SunPhrmInds₹4,46,576.22₹1,613.60 image
₹1,639.50(-1.58%)
₹1,249.800 - ₹1,960.200
Divis Labora₹1,56,123.40₹5,726.40 image
₹5,702.55(0.42%)
₹3,350.050 - ₹6,448.750
Cipla₹1,21,675.13₹1,463.35 image
₹1,476.75(-0.91%)
₹1,240.700 - ₹1,702.000
ManKind Phar₹1,18,478.90₹2,342.10 image
₹2,298.80(1.88%)
₹1,910.100 - ₹3,050.000
DrReddysLab₹1,15,939.04₹1,128.15 image
₹1,164.55(-3.13%)
₹1,104.690 - ₹1,420.200

FAQs on Dipna Pharmachem

What is the share price of Dipna Pharmachem?

The share price of Dipna Pharmachem on 25 Feb, 2025 is ₹ 11.80.

What is 52W high and 52W low share price of Dipna Pharmachem?

The highest and lowest 52W share prices of Dipna Pharmachem are ₹ 14.530 and ₹ 6.400

What is the market cap of Dipna Pharmachem?

The market capitalization of Dipna Pharmachem as of 25 Feb, 2025 is ₹ 28.37 Crores

What is the P/E ratio of Dipna Pharmachem?

The current P/E ratio of Dipna Pharmachem as of 25 Feb, 2025 is 43.77

What is the PB ratio of Dipna Pharmachem?

The PB ratio of Dipna Pharmachem as of 25 Feb, 2025 is 0.76

Top Gainers

948IHFL26I

IBHFL NCD186

₹845.00image

₹705.00 (0.20%)

GREAVESCOT

Greaves

₹281.85image

₹234.90 (0.20%)

ASHSI

Ashirwd Stl

₹45.66image

₹38.05 (0.20%)

CAPRO

Caprola.Chem

₹62.40image

₹52.00 (0.20%)

Top Losers

DHANBANK

Dhanalak.Bnk

₹32.19image

₹35.97 (-0.11%)

08MPD

08MPD

₹8.66image

₹9.62 (-0.10%)

BALTE

BalurghtTran

₹27.13image

₹31.24 (-0.13%)

DARSHANORNA

Darshan Orna

₹4.57image

₹5.07 (-0.10%)

Market Indices

Sensex

₹78,699.07image

₹78,472.48 (0.00%)

Source : Dion Global Solutions Limited